Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02613312 · ClinicalTrials.gov registry record
Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 8
- Enrollment target
NCT02613312: Clinical Trial study, sponsored by Mayo Clinic.
NCT02613312 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02613312 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the response rate and overall survival in patients that have been diagnosed with mesothelioma and will undergo chemotherapy, surgery and intensity modified radiation therapy (IMRT) as part of their standard of care.
Primary Outcome
OS is defined as the length of time from study enrollment to death by any cause. Survival status of patients will be monitored every 6 months
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-03-18 |
| Est. Completion | 2020-10-05 |
Why NCT02613312 stopped before completion
NCT02613312 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02613312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02613312 about?
NCT02613312 is a clinical study titled "Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma". The purpose of this study is to determine the response rate and overall survival in patients that have been diagnosed with mesothelioma and will undergo chemotherapy, surgery and intensity modified radiation therapy (IMRT) as part of their standard of care.
What is the current status of trial NCT02613312?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2016-03-18. Estimated completion is 2020-10-05.
Who is sponsoring clinical trial NCT02613312?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI